Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular tumour boards — current and future considerations for precision oncology
Apostolia M. Tsimberidou, Michael Kahle, Henry Hiep Vo, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 12, pp. 843-863
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Modular CRISPR/Cas12a synergistic activation platform for detection and logic operations
Minghao Hu, Xianzhi Cheng, Tongbo Wu
Nucleic Acids Research (2024) Vol. 52, Iss. 12, pp. 7384-7396
Open Access | Times Cited: 9
CoHIT: a one-pot ultrasensitive ERA-CRISPR system for detecting multiple same-site indels
Yin Liu, Xinyi Liu, Dongyi Wei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Artificial intelligence-based biomarkers for treatment decisions in oncology
Marta Ligero, Omar S.M. El Nahhas, Mihaela Aldea, et al.
Trends in cancer (2025)
Open Access | Times Cited: 1
Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care
Apostolia M. Tsimberidou, Anthony Sireci, Robert Dumanois, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 6, pp. 761-766
Closed Access | Times Cited: 6
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design
Elena Fountzilas, Apostolia M. Tsimberidou, Henry Hiep Vo, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102703-102703
Closed Access | Times Cited: 5
Engineering Stimuli‐Responsive Materials for Precision Medicine
Ruixuan Zheng, Yu Chang, Dan Yao, et al.
Small (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Retrieval Augmented Therapy Suggestion for Molecular Tumor Boards (Preprint)
Eliza Berman, Holly Sundberg Malek, Michael Bitzer, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e64364-e64364
Open Access
A prospective pragmatic evaluation of automatic trial matching tools in a molecular tumor board
Lorraine Gueguen, Louise Olgiati, Clément Brutti-Mairesse, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Knowledge Connector: Decision support system for multiomics-based precision oncology
Daniel Hübschmann, Simon Kreutzfeldt, Benjamin Roth, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Genomics in Cancer of Unknown Primary – Utility in Modern Clinical Practice
Andrew J. Dooley, Anne Ramsay Bowden, H. Whatling, et al.
Clinical Oncology (2025) Vol. 41, pp. 103793-103793
Closed Access
Precision Oncology - Guideline of the Austrian, German and Swiss Societies for Hematology and Medical Oncology
Damian Rieke, Michael Bitzer, Annalen Bleckmann, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115331-115331
Open Access
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status
Christian Issing, Constantin Menche, M. Richter, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Molecular tumour board in gastrointestinal cancers
L. Boscolo Bielo, Edoardo Crimini, M. Repetto, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104510-104510
Closed Access
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients
Julio Herrero Colomina, E. Johnston, Kate Duffus, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps
Beryl Primrose Gladstone, Janina Beha, Arisa Hakariya, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Integrating comprehensive genomic profiling in the management of oncology patients: applications and challenges in Taiwan
Chen‐Yang Huang, Wen‐Kuan Huang, Kun-Yun Yeh, et al.
Biomedical Journal (2025), pp. 100851-100851
Open Access
The burden of rare cancers among adults in the Canton of Geneva, Switzerland, from 2011 to 2020
Nathalie Le Bot, E. Fournier, Marie-Laure Amram, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Near-Infrared Photosensitizers Containing Biscations for Cellular Membrane Targeting Fluorescence Imaging and Photodynamic Therapy
Chang Li, Min Liu, Wen H. Yu, et al.
Dyes and Pigments (2025), pp. 112818-112818
Closed Access
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice
C. Benedikt Westphalen, L. Boscolo Bielo, Philippe Aftimos, et al.
Annals of Oncology (2025)
Open Access
Phenotypic complexities of rare heterozygous neurexin-1 deletions
Michael B. Fernando, Yu Fan, Yanchun Zhang, et al.
Nature (2025)
Closed Access
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis
Niklas Gremke, Fiona R. Rodepeter, Julia Teply‐Szymanski, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1561-1561
Open Access | Times Cited: 4
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL consortium
Gennaro Ciliberto, Ruggero De Maria, Patrizio Giacomini, et al.
European Journal of Cancer (2025), pp. 115433-115433
Closed Access
Copenhagen Prospective Personalized Oncology (CoPPO) – Impact of comprehensive genomic profiling in more than 2000 patients in a Phase I setting
Laïla Belcaid, Martin Højgaard, Ida Elisabeth Viller Tuxen, et al.
Annals of Oncology (2025)
Closed Access
The 1+Million Genomes Minimal Dataset for Cancer
Michela Riba, Cinzia Sala, Aedín C. Culhane, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 733-736
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top